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Human skin cells recognize the presence of the skin microbiome through pathogen
recognition receptors. Epidermal keratinocytes are known to activate toll-like receptors
(TLRs) 2 and 4 in response to the commensal Cutibacterium acnes (C. acnes, formerly
known as Propionibacterium acnes) bacterium and subsequently to induce innate
immune and inflammatory events. These events may lead to the appearance of
macroscopic inflammatory acne lesions in puberty: comedos, papules and, pustules.
Healthy skin does not exhibit inflammation or skin lesions, even in the continuous
presence of the same microbes. As the molecular mechanism for this duality is still
unclear, we aimed to identify factors and mechanisms that control the innate immune
response to C. acnes in keratinocytes using a human immortalized keratinocyte cell
line, HPV-KER, normal human keratinocytes (NHEK) and an organotypic skin model
(OSM). TNIP1, a negative regulator of the NF-κB signaling pathway, was found to
be expressed in HPV-KER cells, and its expression was rapidly induced in response
to C. acnes treatment, which was confirmed in NHEK cells and OSMs. Expression
changes were not dependent on the C. acnes strain. However, we found that the
extent of expression was dependent on C. acnes dose. Bacterial-induced changes
in TNIP1 expression were regulated by signaling pathways involving NF-κB, p38,
MAPKK and JNK. Experimental modification of TNIP1 levels affected constitutive and
C. acnes-induced NF-κB promoter activities and subsequent inflammatory cytokine
and chemokine mRNA and protein levels. These results suggest an important role for
this negative regulator in the control of bacterially induced TLR signaling pathways in
keratinocytes. We showed that all-trans retinoic acid (ATRA) induced elevated TNIP1
expression in HPV-KER cells and also in OSMs, where TNIP1 levels increased throughout
the epidermis. ATRA also reduced constitutive and bacterium-induced levels of TNFα,
CCL5 and TLR2, while simultaneously increasing CXCL8 and TLR4 expression. Based
on these findings, we propose that ATRAmay exhibit dual effects in acne therapy by both
affecting the expression of the negative regulator TNIP1 and attenuating TLR2-induced
inflammation. Overall, TNIP1, as a possible regulator of C. acnes-induced innate immune
and inflammatory events in keratinocytes, may play important roles in the maintenance
of epidermal homeostasis.
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INTRODUCTION
The human skin harbors a specialized microbiome, which
plays an important role in the regulation and maintenance of
epidermal homeostasis. Various members of the microbiome are
also important in the pathogenesis of several skin diseases, most
of which lead to exaggerated innate immune and inflammatory
events. Examples of pathogenesis involving bacteria present in
the microbiome include Malassezia spp in seborrheic dermatitis,
Staphylococcus aureus in atopic dermatitis and Cutibacterium
acnes (C. acnes, formerly known as Propionibacterium acnes) in
acne vulgaris (1–4).
C. acnes becomes a dominant species in the pilosebaceous
units during puberty by colonizing the hair follicle region,
often forming a biofilm (5, 6). Human epidermal keratinocytes
sense the presence of this bacterium with pathogen recognition
receptors. C. acnes recognition is mostly mediated by the
activation of toll-like receptors (TLRs) 2 and 4, induction
of the canonical signaling pathway and subsequent innate
immune and inflammatory events (7, 8). An important mediator
of this cascade is the NF-κB transcription factor, which
regulates the expression of key genes in the initialization and
maintenance of downstream responses. These genes include
different cytokines, such as tumor necrosis factor α (TNFα),
interleukin (IL) 1α, IL1β, and IL6, chemokines, such as C-X-C
motif chemokine ligand 8 (CXCL8) and C-C motif chemokine
ligand 5 (CCL5), antibacterial peptides, such as human beta
defensin 2 (hBD2), and other inflammatory mediators (9,
10). The innate immune activation of keratinocytes and the
inflammatory milieu they generate in their environment favors
the activation of other cell types, including sebocytes, dendritic
cells and macrophages. Adaptive immune events are also
induced, leading to the activation of the Th1/Th17 pathway
(11, 12). Overall, these events contribute to the induction
of the characteristic inflammatory symptoms during disease
pathogenesis in adolescents. Inflammation and acne lesions
are generally present transiently. In adolescents the inflamed
follicles heal by themselves and the affected individuals often
do not exhibit any residual signs. In the early twenties, even
after resolution of the disease, C. acnes still dominates the
microflora, especially in the sebum-rich skin regions. However,
the bacterium does not usually provoke immune activation
and inflammation in keratinocytes and/or other immune cells.
This age-dependent response to C. acnes indicates different
mechanisms controlling the downstream events induced by the
bacterium.
Several negative regulators of the TLR and NF-κB signaling
pathways have been identified in the past decade (13, 14).
Through their regulatory functions, these negative regulators
play important roles in the protection against extreme and
prolonged activation of TLR and NF-κB downstream elements,
both of which may lead to uncontrolled inflammation and
tissue damage. TNIP1 (TNFAIP3 interacting protein 1), one such
negative regulator, was identified as an interacting partner of
TNFAIP3 (TNF alpha induced protein 3). TNIP1 has been shown
to affect different signaling pathways by interacting directly with
various proteins, including NEMO, TRAF1, p105, FADD, and
RIP1. As a consequence, the transcription factor NF-κB and
the TLR-MYD88 signaling cascade is inhibited and apoptotic
and autoimmune events are negatively affected (15, 16). TNIP1
is known to be expressed in keratinocytes, where this protein
controls cell proliferation partly due to the regulation of ERK1/2
signaling (17). TNIP1 promoter activity may be regulated by
NF-κB, PPAR, retinoic acid receptors and also SP sites. These
factors contribute to its basal and inducible activation possibly
in a cell-type-specific manner (18–20). TNIP1’s role in the
regulation of TLR signaling in keratinocytes has been suggested
in a recent study showing that its attenuation sensitizes HaCaT
keratinocytes to synthetic TLR ligand treatment (21).
Currently, it is not clear whether negative regulators of the
TLR and NF-κB signaling pathways play a role in the regulation
of human microbiome-induced signaling events. Thus, we aimed
to analyse the possible role of TNIP1 in C. acnes-induced
innate immune and inflammatory events using in vitro cultured
immortalized human keratinocytes and organotypic skin models
(OSMs).
Our results show that, upon C. acnes treatment, TNIP1
expression is rapidly induced in a dose-dependent manner, and
this induction is regulated by the NF-κB and JNK pathways
and to some extent by p38- and MAPKK-dependent signaling
pathways. In addition, modified TNIP1 levels affect the outcome
of bacterium-induced molecular events, suggesting that this
molecule acts through a negative regulatory feedback loop.
Retinoids, including all-trans retinoic acid (ATRA), are
used as effective acne drugs and act by promoting cell
proliferation, inhibiting keratinocyte terminal differentiation,
decreasing sebum production and, as a result, indirectly reducing
the amount of C. acnes (22). We aimed to investigate whether
ATRA also affects the innate immune function of keratinocytes
and found that ATRA treatment increases TNIP1 expression
levels in our model systems. Our results reveal a possible mode
of retinoid action that has not been explored previously.
MATERIALS AND METHODS
Cell Cultures and Models
The human immortalized keratinocyte cell line HPV-KER (23)
and normal human epidermal keratinocytes (NHEK) were
used for our experiments. Both cell types were cultured in
keratinocyte serum-free medium (KSFM, Life Technologies,
Carlsbad, United States) containing 1% antibiotic/antimycotic
(AB/AM, Sigma Aldrich, St. Louis, MO, United States) solution
and supplemented with epidermal growth factor and brain
pituitary extract under standard laboratory conditions (37◦C in
a humidified atmosphere containing 5% v/v CO2).
NHEKs and ex vivo skin biopsies were obtained from
skin specimens collected from the Plastic Surgery Unit of
our department. Written informed consent was obtained from
investigated individuals. The study was approved by the Human
Investigation Review Board of the University of Szeged (PSO-
EDAFN-002, 23 February 2015, Szeged, Hungary) and complying
with the ethical standards in accordance with the Helsinki
Declaration. NHEK cells were isolated from the skin samples
as described earlier (24). For ex vivo organotypic skin models
Frontiers in Immunology | www.frontiersin.org 2 September 2018 | Volume 9 | Article 2155
Erdei et al. TNIP1 Regulates C. acnes-Induced Inflammation
(OSMs), 6mm punch biopsies were washed first with normal
saline solution (NSS) containing 2% AB/AM, followed by a wash
in AB/AM-free NSS. Subsequently, they were placed onto the
upper chambers of Transwell R© cell culture inserts (Corning,
New York, United States) and kept at the air-liquid interphase.
This way, the dermal part of the biopsies were in contact with
DMEM F12 liquid culture medium (Lonza, Basel, Switzerland)
supplemented with 10% fetal bovine serum (EuroClone, Milan,
Italy) lacking AB/AM.
Treatments
For bacterial treatment, HPV-KER and NHEK cells were plated
in AB/AM-free KSFM culture medium and co-cultured with live
C. acnes strains belonging to different phylogenetic groups within
the species (889, ATCC 11828, 6609) at various multiplicity of
infection (MOI). Ex vivo skin models were treated with the C.
acnes 889 strain at a density of 3× 107 cfu/cm2 for 24 h. C. acnes
strains were cultured and stored as previously described in detail
(10).
To analyze the effect of the active form of retinoic acid, ATRA
was dissolved in DMSO and a 10−6 M concentration was applied
to HPV-KER cells for 48 h before C. acnes challenge. ATRA was
applied to OSMs at a 1.5 × 10−6 M concentration for 24 h. As
a control, cells were subjected to DMSO treatment without the
active ingredient.
The selective inhibitors of JNK (sp 600125, 10µM), NF-
κB (Bay 11-7085, 10µM), p38 (sb 203580, 10µM), MAPKK
(PD 098059, 20µM), STAT1 (Fludarabine, 25µM) and STAT3
(Stattic, 5µM), or, as a control, DMSO were applied to the
cells for 1 h (all reagents from Sigma Aldrich, St. Louis, MO,
United States).
Transfection, Plasmids and
siRNA-Mediated Gene Silencing
Transient transfection experiments were performed using the
X-tremeGENE 9 DNA Transfection Reagent (Roche, Indiana,
United States). For the overexpression studies, HPV-KER cells
were plated in 12-well plates (100,000 cells/well), transfected
for 24 h with 0.5 µg empty pcDNA3.1 vector or pcDNA3.1-
TNIP1 vector into which TNIP1 cDNA sequences (OriGene
Technologies, Inc., MD, United States) had been inserted.
Transfection-grade plasmid was prepared using the E.Z.N.A
Endo-free plasmid DNA Maxi Kit (Omega Bio-tek, Inc., GA,
United States).
For siRNA-mediated gene silencing, siRNA was delivered by
the Santa Cruz siRNA Transfection Reagent (Santa Cruz
Biotechnology, Texas, United States) according to the
manufacturer’s instructions. ON-TARGETplus SMARTpool
TNIP1 siRNA or ON-TARGETplus Non-targeting Pool
(Dharmacon, Lafayette, United States) constructs were used at a
concentration of 10 nM.
A NF-κB luciferase reporter assay was performed using
the PathDetect pNF-κB-Luc Cis-Reporter Plasmid (Stratagene,
California, USA), pGL4.75[hRluc/CMV] Vector and the Firefly
& Renilla Dual Luciferase Assay Kit (Biotium Inc., California,
United States), according to the manufacturer’s instructions.
ELISA
C. acnes-treated and control HPV-KER cell culture supernatants
were collected and the levels of secreted CXCL8 (R&D Systems,
Minneapolis, United States), IL-6 and CCL5 (PeproTech EC
Ltd., London, United Kingdom) were measured according to the
manufactures’ instructions.
RNA Isolation, cDNA Synthesis and
Real-Time RT-PCR
Total RNA was isolated using TRI-Reagent (Molecular Research
Center; Cincinnati, United States). cDNA synthesis was
performed using 1 µg RNA with the iScript TM cDNA Synthesis
kit (Bio-Rad, Hercules, United States). Changes in mRNA
expression were detected by real-time RT-PCR using the
Universal Probe Library (Roche, Indiana, United States) or the
TaqMan Gene expression Assay (Thermo Scientific, Rockford,
United States). Supplementary Table 1 lists the PCR protocols
and primer sequences used. All data were normalized to the
18S rRNA using the 11Ct method and compared to the
time-matched untreated control samples.
Protein Isolation and Western Blot Analysis
For the preparation of whole cell lysates, samples were collected
and lysed in lysis buffer containing 20mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid, 150mM KCl, 1mM MgCl2,
1mM DTT, 5% Triton X-100, 10% glycerol, 0.1% NP-40,
1% Protease Inhibitor Cocktail, phenylmethylsulfonyl fluoride
and 0.5% sodium dodecyl sulfate (SDS) (all from Sigma
Aldrich, St. Louis, MO, United States). Protein concentrations
were measured with the BCA Protein Assay Kit (Thermo
Scientific, Rockford, United States). Samples (50 µg) were
separated on a 7.5% SDS polyacrylamide-gel electrophoresis
and transferred to nitrocellulose membrane (Bio-Rad, Hercules,
United States), blocked in Tris-buffered saline (TBS) containing
5% Blotting-Grade Blocker (Bio-Rad, Hercules, United States).
Membranes were incubated over-night at 4◦C with primary anti-
TNIP1 antibody diluted 1:500 and anti-actin (Sigma Aldrich,
St. Louis, MO, United States) diluted 1:1,000. Subsequently,
membranes were incubated for 2 h at room temperature with
a horseradish peroxidase-conjugated anti-rabbit IgG (Santa
Cruz Biotechnology, Texas, United States) secondary antibody
diluted 1:2,000. Proteins were visualized with luminol (Bio-Rad,
Hercules, United States) using a Omega LumTM G Imaging
System (Gel Company, CA, United States).
Fluorescence Microscopic Analysis
HPV-KER cells were grown on glass sides, fixed with 2%
paraformaldehyde (PFA) for 5min, permeabilized with 0.1%
Triton X, 2% PFA-containing phosphate-buffered saline (PBS),
and blocked for 2 h at room temperature with PBS containing
1% bovine serum albumin (BSA), 0.05% Triton X 100, and 10%
goat serum. Cells were stained overnight at 4◦C with anti-human
TNIP1 antibody (Sigma Aldrich, St. Louis, MO, United States)
or rabbit IgG for isotype control. As a secondary antibody,
Alexa Fluor 488 conjugated anti-rabbit IgG, was used for 2 h.
Filamentous actin was stained by Alexa Fluor 546 R© phalloidin
(Life Technologies, Carlsbad, United States) diluted 1:100 in PBS
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containing 1% BSA for 20min. Nuclei were stained for 10min
with 4′,6-diamidino-2-phenylindole (DAPI) diluted 1:500.
Frozen sections of ex vivo skin models were pre-incubated
with PBS for 5min and fixed and permeabilized with Foxp3
staining buffer set (Thermo Scientific, Rockford, United States)
and blocked for 1 h at room temperature with TBS containing 1%
BSA and 1% normal goat serum. Cells were stained for 1 h with
anti-human TNIP1 antibody or rabbit IgG for isotype control. As
a secondary antibody, Alexa Fluor 546 conjugated anti-rabbit IgG
(Thermo Scientific, Rockford, United States), was used for 1 h
at room temperature. Nuclei were stained for 6min with DAPI
diluted 1:100.
Statistical Analysis
Unless otherwise noted, all data are presented as mean ±
standard error of the mean (SEM) for three independent
experiments. For real-time RT-PCR analyzes and enzyme-
linked immunosorbent assay (ELISA), each treatment was
performed at least in triplicate; for western blot and fluorescence
microscopic analysis each treatment was performed once in every
independent experiment. Data were compared using paired, two-
sample t-test with False Discovery Rate (FDR) correction. A
probability value of less than 0.05 was considered significant.
RESULTS
TNIP1 Is Expressed in Keratinocytes and
its Expression Increases in Response to
the Presence of C. acnes
Initially, we aimed to analyse changes in TNIP1 expression in
in vitro cultured keratinocytes after treatment with C. acnes.
For this purpose, NHEK or HPV-KER cells were treated with
the bacterium. Keratinocyte to C. acnes ratios were determined
in extensive preliminary studies. We chose conditions which
induced relatively fast and reproducible cellular responses, but
did not induce cell death in the time course of our studies (23).
We found that TNIP1 is expressed in HPV-KER cells and
that mRNA expression rapidly and significantly increased afterC.
acnes 889 treatment (MOI= 100), reaching the maximum at 12–
24 h (Figure 1A). These findings suggest that these cells recognize
the presence of C. acnes bacterium.
It has been suggested that various C. acnes strains may have
different effects on the cellular and molecular properties of
human keratinocytes (10). We applied C. acnes strains (MOI
= 100) belonging to various phylogenetic groups within the
species (C. acnes 889, 6609, ATCC 11828, Group IA, IB, and
II.) and compared the effects. No strain-specific differences
were observed: all of the C. acnes strains used induced similar
changes in mRNA expression in HPV-KER cells (Figure 1B).
Subsequently, only the C. acnes 889 strain was used in further
experiments.
We also found, that bacterium-induced changes in TNIP1
expression were dose-dependent: the abundance of mRNA
increased in parallel with increasing C. acnes 889 bacterial doses
(Figure 1C).
Next, we analyzed TNIP1 protein levels in HPV-KER cells
using western blot analysis and immunocytochemistry. Elevated
TNIP1 levels were detected in the 6 h samples and remained
high during the time-course of the experiment (Figure 1D).
Immunocytochemical staining of TNIP1 resulted in the presence
of immunofluorescent dots, occurring mostly in the perinuclear
region of HPV-KER cells. The number of labeled dots increased
after 24 h of C. acnes treatment (MOI = 100) (Figure 1E).
Similarly to the mRNA levels, the abundance of TNIP1
protein increased in parallel with increasing C. acnes 889 doses
(Figure 1F).
To identify which signaling pathways are involved in
the regulation of constitutive and C. acnes-induced TNIP1
expression levels in keratinocytes, we treated HPV-KER cells
with specific inhibitors of well-known representatives (JNK, NF-
κB, p38, MAPKK, STAT1, and STAT3) of different signaling
pathways before the C. acnes treatment and analyzed subsequent
changes in TNIP1 mRNA expression by real-time RT-PCR.
We found that constitutive TNIP1 expression was significantly
decreased when JNK and MAPKK were inhibited. Furthermore,
C. acnes-induced changes in TNIP1 expression diminished in
response to inhibition of JNK and MAPKK as well as of NF-κB
and p38. In contrast, no effect was observed with STAT1 and
STAT3 inhibition (Figure 1G).
To confirm that C. acnes-induced TNIP1 expression changes
were not specific to the HPV-KER cell line, we repeated the
experiments using NHEK cells and found similar results. TNIP1
mRNA levels increased in response to C. acnes treatment
(Figure 1H), and increased protein levels were also noted in
NHEK cell cultures 24 h after treatment (Figure 1I).
To confirm that the observed results were not specific
to keratinocyte monolayer cultures, we also repeated the
experiments using an ex vivo, OSMs. Punch biopsies of full
thickness skin samples from healthy donors were cultured at the
air–liquid interphase and C. acnes 889 was applied to the top
(epidermal side) of the samples. We found that TNIP1 protein
was expressed throughout the epidermis, and that slightly higher
levels were detected in the less differentiated, basal layers. Within
the keratinocytes, localization was primarily cytoplasmic and
perinuclear. Elevated TNIP1-staining levels were found 24 h after
C. acnes treatment (Figure 1J).
TNIP1 Down-Regulates Both Constitutive
and C. acnes-Induced Inflammatory
Cytokines and Chemokines Expression
To analyze the role of TNIP1 in the regulation of C. acnes-
induced inflammatory events, we experimentally modified
endogenous TNIP1 levels with cDNA-based transient
overexpression or siRNA-mediated silencing. We monitored
the expression of selected pro-inflammatory cytokines and
chemokines that are known downstream targets of the TLR
signaling pathway, as well as the promoter activity of the NF-κB
transcription factor, using real-time RT-PCR, ELISA analysis and
a luciferase- reporter assay.
cDNA-based transient overexpression resulted in markedly
increased TNIP1 protein levels in HPV-KER cells (Figure 2A).
As a consequence, significantly decreased constitutive and C.
acnes-induced NF-κB promoter activities were measured in
the subsequent luciferase reporter assay (Figure 2B). mRNA
Frontiers in Immunology | www.frontiersin.org 4 September 2018 | Volume 9 | Article 2155
Erdei et al. TNIP1 Regulates C. acnes-Induced Inflammation
FIGURE 1 | mRNA and protein expression of TNIP1 increases in response to C. acnes treatment. HPV-KER cells (A–G), NHEK cells (H,I) and an ex vivo skin model
(J) were treated with C. acnes 889 at a MOI of 100, unless otherwise indicated, and changes in mRNA and protein levels were analyzed. (A,B,C,H) Changes in TNIP1
mRNA expression were analyzed by real-time RT-PCR; data were normalized to 18S rRNA using the 11Ct method and compared to the time-match untreated
control values. Error bars are SEM. Statistical analyzes: paired, two-sample t-test with FDR correction: *p < 0.05, **p < 0.01, ***p < 0.001. (G) HPV-KER cells were
plated and pretreated with selective inhibitors for JNK, NF-κB, p38, MAPKK, STAT1 and STAT3 or, as a control, DMSO for 1 h. C. acnes challenge was performed for
12 h and samples were collected for subsequent mRNA analyzes by real-time RT-PCR. All data were normalized to the 18S rRNA using the 11Ct method and
compared to DMSO-treated control samples. Statistical analyzes: paired, two-sample t-test with FDR correction, basal TNIP1 expression *p < 0.05, **p < 0.01 or C.
acnes-induced TNIP1 expression, #p < 0,05, ###p < 0.001. were compared. (D,F) TNIP1 protein was detected with western blot analysis and quantitated using an
Image Pro Plus, where all data were normalized to actin; a representative blot is shown. Statistical analyzes: paired, two-sample t-test: *p < 0.05. (E) After 24 h C.
acnes treatment, HPV-KER cells were visualized with immunofluorescence staining for TNIP1 (green), Phalloidin (red) and DAPI (blue). (I) NHEK cells were treated with
C. acnes and TNIP1 protein was detected with western blot analyzes (a representative experiment). (J) OSMs were treated with 3 × 107 bacterium for 24 h, and cells
were visualized with immunofluorescence staining for TNIP1 (green) and DAPI (blue), where empty arrows indicate cytoplasmic location and filled arrows indicated
perinuclear localization.
expression of constitutive and C. acnes-induced TNFα, CXCL8
and CCL5 also decreased compared to the empty-vector
transfected samples. In addition, bacterium-induced mRNA
levels of IL6 decreased, whereas IL1α levels were not affected
(Figure 2C). Overexpression of TNIP1 also decreased IL-6,
CXCL8, and CCL5 protein secretion (Figure 3A).
In contrast, siRNA-mediated silencing of TNIP1 led to
markedly decreased TNIP1 protein levels (Figure 2D). As a
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FIGURE 2 | Effects of TNIP1 levels on the downstream targets of the TLR signaling pathway. After plating HPV-KER cells, TNIP1 overexpression (24 h) (left panel) or
siRNA-mediated silencing (48 h) (right panel) was performed. Subsequently, cells were treated with C. acnes (MOI = 100) for 6 h. (A,D) TNIP1 protein levels were
analyzed by western blot after overexpression or silencing and quantitated using Image Pro Plus, where all data were normalized to actin; a representative blot is
shown. Error bars are SD. (B,E) NF-κB promoter activities were measured with a luciferase reporter assay; data were normalized to signal from a vector constitutively
expressing Renilla luciferase and compared to time-matched samples transfected with vectors that were empty (pcDNA3.1) or contained scr-siRNA. (C,F) mRNA
levels of TNFα, IL-6, CXCL8 and CCL5 were analyzed by real-time RT-PCR; data were normalized to 18S rRNA using the 11Ct method and compared to
time-matched samples transfected with vectors that were empty (pcDNA3.1) or contained scr-siRNA. Error bars are SEM. Statistical analyzes: paired, two-sample
t-test: *p < 0.05, **p < 0.01, ***p < 0.001.
consequence, significantly increased constitutive and bacterial
induced NF-κB promoter activities were found in a luciferase
reporter assay (Figure 2E). Constitutive and C. acnes-induced
expression of TNFα, CXCL8, and CCL5 mRNA markedly
increased, whereas IL1α and IL6 expression increasedmoderately
in response to TNIP1 silencing (Figure 2F). Constitutive and
bacterium-induced secretion of CXCL8, IL6, and CCL5 were also
elevated in TNIP1 silenced HPV-KER cells (Figure 3B).
ATRA Induces TNIP1 Expression and
Affects the Levels of Downstream Targets
of the TLR Signaling Pathway
The TNIP1 promoter contains retinoic acid response elements
(RARE) and retinoid-acid-receptor binding sites. These elements
are involved in the induction of TNIP1 expression by retinoic
acid under permissive epigenetic conditions in different cell lines
(19). Since ATRA is an effective drug used for acne treatment,
we examined whether this compound is capable of regulating
TNIP1 and, thus, the expression of downstream targets of the
TLR signaling pathway in keratinocytes.
We observed that ATRA treatment led to slightly elevated
TNIP1 mRNA levels, although this effect was not statistically
significant (Figure 4A), and to significantly increased TNIP1
protein expression (Figure 4B). In addition, constitutive and
C. acnes-induced mRNA expression of TLR-2 and the pro-
inflammatory TNFα and CCL5 decreased upon ATRA treatment.
In contrast, both constitutive and C. acnes-induced TLR-4 and
CXCL8 mRNA expression levels increased, whereas TLR3 and
IL-6 mRNA levels were not affected by the drug (Figures 4D,E).
To confirm that the effects of ATRA on TNIP1 expression
were not specific to the HPV-KER cell line, we also applied the
drug to the upper, epidermal part of OSMs.We found that TNIP1
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FIGURE 3 | Effects of TNIP1 levels on secretion of pro-inflammatory cytokine and chemokine. After plating HPV-KER cells, (A) TNIP1 overexpression (24 h) or (B)
siRNA-mediated silencing (48 h) was performed. Subsequently, cells were treated with C. acnes (MOI = 100) for 24 h. Secreted cytokine and chemokine levels were
measured by ELISA and relative protein levels are presented. Data were normalized to time-matched samples transfected with a vector that was empty (pcDNA3.1) or
contained scr-siRNA. Values of the measured protein levels were the following: IL-6: 200–1,300 pg/ml, CXCL8: 200–2,800 pg/ml, CCL5: 50–400 pg/ml. Error bars are
SEM. Statistical analyzes: paired, two-sample t-test: *p < 0.05, **p < 0.01, ***p < 0.001.
protein expression levels had increased in all epidermal layers
24 h after ATRA treatment (Figure 4C), in a manner similar to
observed for immortalized keratinocytes.
DISCUSSION
Human skin harbors a special microbiota which protects against
pathogens, helps to maintain the proper functions of the skin and
also serves as an immunological barrier, functions that have also
been proposed for the gut microbiota (25). These skin functions
are partly achieved by keeping the immune system at a basal
activated state. Low levels of TLR activation may contribute to
the maintenance of basal expression from genes with important
roles for the immunological barrier (e.g., inducible antimicrobial
peptides, such as hBD2) (26).
Under healthy conditions, these events do not lead to
inflammatory processes. However, under certain conditions, the
commensal bacteria are involved in inflammatory skin diseases,
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FIGURE 4 | ATRA induces TNIP1 expression and affects the expression of TLRs and downstream targets of the TLR signaling pathways. HPV-KER cells (A,B) were
treated with 10−6 M ATRA for 48 h or ex vivo skin (C) with 1.5 × 10−6 M for 24 h, and TNIP1 mRNA and protein levels were analyzed. (D,E) HPV-KER cells were
treated with 10−6 M ATRA for 48 h and challenged with C. acnes (MOI = 100) for 6 h. mRNA expression of TLRs and selected pro-inflammatory molecules was
analyzed. mRNA expression changes were detected by real-time RT-PCR; data were normalized to the 18S rRNA using the 11Ct method and compared to the
untreated control values. Error bars are SEM. (B) TNIP1 protein was detected by western blot analysis and quantitated using an Image Pro Plus; a representative blot
is shown, or (C) was visualized with immunofluorescence staining for TNIP1 (green) and DAPI (blue). Statistical analyzes: paired, two-sample t-test: *p < 0.05, **p <
0.01, ***p < 0.001.
such as acne (27, 28). The mechanisms underlying this duality –
the protective and pathogenic aspects of the continual presence
of the skin microbiota – are still unclear (1, 25) C. acnes, a
dominant member of the human skin microbiome, is recognized
by TLR2 and TLR4 in human epidermal keratinocytes. This
bacterium can induce innate immune and inflammatory events,
such as production of inflammatory cytokines, chemokines,
antimicrobial peptides and other inflammatory mediators, as
well as autophagy in keratinocytes, and, through this induction,
plays a role in the pathogenesis of acne vulgaris (7, 8, 27, 29).
However, at the beginning of early adolescence this bacterium is
overwhelming dominant in the skin microbiota under healthy
conditions, yet does not induce macroscopically detectable
inflammation (3, 5). These observations suggest that one or more
mechanisms regulate C. acnes-induced immune activation.
In the past decades, several negative regulators of TLR
and the NF-κB signaling pathway have been identified. The
regulatory functions of these molecules play important roles in
the protection against exaggerated immune activation. Since their
discovery, an increasing number of publications has reported
correlation between genetic variations of these proteins and
altered expression and/or dysfunctional proteins as well as with
diseases associated with inflammation, such as psoriasis, systemic
lupus erythematosus and cancer (13, 16, 30). Taken together,
these results suggest that proper regulation and function of these
factors are indispensable for the maintenance of health. The role
of these molecules in the assuagement of microbiome-induced
immune activation has not yet been investigated.
In our study, we analyzed TNIP1, a regulator of NF-κB
signaling pathways, and found that it is a possible negative
regulator of C. acnes-induced inflammatory events in HPV-
KER cells. TNIP1 is expressed in cultured keratinocytes and
mRNA and protein expression increased in response to C. acnes
treatment; the extent of activation was dependent on the bacterial
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dose. We confirmed that these changes were not specific for
the HPV-KER cell line, as similar results were obtained using
NHEK cells. In ex vivoOSMs we showed that TNIP1 is expressed
in all epidermal layers, which was consistent with previous
studies (17). We detected mostly cytoplasmic and perinuclear
staining within the keratinocytes, in contrast to previous studies,
where cytoplasmic and also intensive nuclear staining of TNIP1
was observed in HaCaT cells (17, 31). In response to C. acnes
treatment, elevated TNIP1 levels were found in the epidermis.
These results are in agreement with our findings using NHEK
and HPV-KER cells: TNIP1 expression changes in keratinocytes
in response to the presence of the bacterium. These findings show
that, in addition to pro-inflammatory mediators, C. acnes also
induces the expression of anti-inflammatory factors, possibly to
avoid excessive inflammation and immune activation. Our results
strongly suggest that TNIP1may be one of the negative regulators
of C. acnes-induced molecular events.
Earlier studies revealed differences in C. acnes strain-
composition from healthy individuals and acne patients (32). It
has been suggested that strains belonging to various phylogenetic
groups within the species differentially affect the cellular and
molecular properties of keratinocytes (10). In the present
study, we did not observe strain-specific differences in TNIP1
expression in response to C. acnes, suggesting that strain-specific
activation of keratinocytes are not related to the ability of the
bacterium to induce the studied negative regulators.
In silico analyzes predicted the presence of putative biding sites
for NF-κB, AP-1, SP and C/EBPβ (33, 34) in the TNIP1 promoter
region. Gene expression and ChIP assays have confirmed that
NF-κB and SP1 binding sites are active in HeLa cells (18, 20). Our
finding that specific JNK, NF-κB, p38 and MAPKK inhibitors
decreased the bacterium-induced upregulation of TNIP1 suggest
that these signaling pathwaysmay be involved in the regulation of
C. acnes-induced TNIP1 expression in keratinocytes. Moreover,
the intricate pattern of TNIP1 regulation suggests this molecule
may have important roles in different processes.
To confirm the negative regulatory role of TNIP1 in C. acnes-
induced molecular events, we modified its endogenous levels
by cDNA-based overexpression and siRNA-mediated silencing
and examined the expression of downstream elements of TLR
signaling pathways. NF-κB, one of the main mediator of
signaling cascades activated in our experiments, is induced
upon exposure to bacteria (7, 10). Our results, that TNIP1
overexpression decreased basal and C. acnes-induced NF-κB
promoter activities and mRNA levels of TNFα, CXCL8 and
CCL5 as well as secretion of CXCL8, IL-6 and CCL5 correlate
well with findings on other cell types. In HeLa cells, TNIP1
overexpression inhibited constitutive TNFα, IL1α expression and
lipopolisaccharide (LPS)-induced activation of NF-κB (15, 35).
In TNIP1-silenced cells, we observed increased constitutive
NF-κB promoter activities and elevated pro-inflammatory
cytokine and chemokine mRNA and protein levels. TNIP1
silencing also increased C. acnes-induced NF-κB promoter
activity, mRNA levels and secretion of the mediators mentioned
above. These results further support the conclusion that
TNIP1 plays a role in the regulation of C. acnes-induced
events in HPV-KER cells and possibly in the maintenance
of homeostatic conditions. In a recent report, the authors
have also demonstrated that TNIP1-silenced HaCaT cells were
hypersensitive to synthetic TLR3 and TLR2/6 ligands and
subsequently increased JNK and p38 phosphorylation and
nuclear translocation of NF-κB. They also observed increased
levels of secreted IL6 and CXCL8 compared to control cells (21).
Overall, these data indicate a negative regulatory role of TNIP1
in TLR signaling events in keratinocytes.
Other reports have also shown the importance of TNIP1
as a gatekeeper in NF-κB, JNK and p38 mediated processes,
including the prevention of fetal liver apoptosis in a murine
model and TNFα-induced apoptosis in different cell lines (36,
37). In contrast, although TNIP1-deficient mice develop a
progressive, lupus-like inflammatory disease, isolated TNIP1-
deficient macrophages and dendritic cells showing no differences
in pro-inflammatory signaling pathways with respect to IκBα
degradation and resynthesis and phosphorylation of different
MAPKs (p38, ERK1/2, and JNK1/2) compared to wild type mice
upon CpG-DNA or TLR4 (LPS) stimulation (38, 39). These
findings suggest that the role of TNIP1 during TLR activation
might be cell-type specific and depends on the nature of the
stimuli.
Earlier studies found functional RARE elements in the TNIP1
promoter region, and that TNIP1 was induced by ATRA in HeLa
cells under permissive epigenetic conditions, in the presence
of Trichostatin A co-treatment (19). Trichostatin A inhibits
histone deacetylase I and II and alters gene expression by
opening chromatin and allowing transcription factors to bind,
thus, promoting transcription of different genes. We applied
ATRA, an active form of retinoic acid, to HPV-KER cells
and found that TNIP1 mRNA and protein expression levels
increased in response to the treatment without the addition
of chromatin-modification agents. Furthermore, treatment of
OSMs led to similar results throughout the entire epidermis,
suggesting that these effects were not specific to HPV-KER cells.
It is not currently clear why HeLa cells behaved differently;
however, differences in the duration of ATRA exposure or in the
responsiveness of the different cells used might be responsible.
Despite the fact that retinoids, including ATRA, are widely
used as an effective drug for acne therapy, the exact mechanism
of action is not completely understood. Retinoids have been
shown to promote cell proliferation, inhibit keratinocyte terminal
differentiation, decrease the size of sebaceous glands and,
indirectly, reduce the amount of C. acnes (40). Studies of the
effect of retinoids on innate immunity are limited, and the
results are often dependant on the cells used (19, 41–44). In
most cases, ATRA application to monocytes and macrophages
decreased TLR2 abundance as well as the expression of selected
pro-inflammatory mediators; however, the mechanism of these
effects remains unclear (43, 45, 46).
In our experiments, ATRA treatment decreased the level of
constitutive and C. acnes-induced pro-inflammatory mediators
TNFα and CCL5, but increased CXCL8 levels. These results are
consistent with the findings of others; similar CXCL8 expression
changes were observed in NHEK and also in other cell types in
response to ATRA (41, 42, 47). In NHEK cells, NF-κB and p38
signaling might contribute to these events (41).
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Based on all these data, we conclude that ATRA may regulate
TNIP1 expression and, as a consequence, negatively affect
C. acnes-induced inflammatory events in keratinocytes. Our
proposed model may offer a possible, novel mode of retinoid
action in acne treatment.
TLR2 expression is increased in the epidermis and monocytes
isolated from acne patients compared to healthy controls, and
this increase might be a result of C. acnes-induced inflammatory
events. ATRA treatment decreased TLR2 levels in monocytes
isolated from both healthy donors and acne patients following
isotretinoin therapy, although TLR4 expression was not affected
(7, 45, 46, 48, 49). We found similar changes in expression
for TLR2 (decreased) and TLR4 (increased) in HPV-KER cells,
suggesting that ATRA has opposite effects on these two receptors
in keratinocytes.
We propose that the increased bacterial load in acne-
prone follicles is a factor leading to the formation of
inflammatory symptoms. Retinoids may attenuate C. acnes-
induced inflammation by decreasing the sizes of sebaceous glands
and sebum secretion and, subsequently, control the C. acnes
load. In addition, TLR2 levels are also attenuated, preventing
the sensing of this Gram-positive bacterium, which leads to
deleterious inflammation. By decreasing the expression of TLR2,
an important gatekeeper of the skin, the risk of opportunistic
infections is increased. To modulate this effect, expression of
another gatekeeper, TLR4 is elevated. Thus, multiple levels of
sensing and signal transduction may be available in the defense
against potentially harmful microbial invaders. The fact that
opportunistic bacterial and fungal infections are rare in the
lesional skin of acne patients is consistent with our hypothesis.
TNIP1 may regulate C. acnes-induced signaling events
through the establishment of a negative-regulatory feedback
loop controlling NF-κB activity in keratinocytes. Other signaling
pathways, such as nuclear-receptor signaling cascades that are
activated by retinoids, may also affect TNIP1 levels, which in
turn can modify the outcome of the induced processes. Based
on our results, TNIP1 may function as a negative regulator
in keratinocytes that controls bacterium-induced inflammatory
events, playing an important role in maintaining the homeostasis
between skin cells and the skin microbiome. Development of
novel, well-tolerated, TNIP1-specific acne therapeutic modalities
could potentially reduce inflammation without the harmful
side effects of currently available treatment options (antibiotic,
retinoid or hormonal formulation usage).
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